Mitxelena, Asier, and Maria Areses. 2022. “Bezlotoxumab Can Reduce the Risk of Clostridium Difficile Recurrence”. Osagaiz: Osasun-Zientzien Aldizkaria 6 (1). https://aldizkariak.ueu.eus/index.php/osagaiz/article/view/362.